{"id":16369,"date":"2022-10-19T10:31:17","date_gmt":"2022-10-19T08:31:17","guid":{"rendered":"https:\/\/convergences.online\/hemato\/?page_id=16369"},"modified":"2024-01-05T14:26:49","modified_gmt":"2024-01-05T13:26:49","slug":"eha-2022","status":"publish","type":"page","link":"https:\/\/www.hematostat.net\/en\/eha-2022\/","title":{"rendered":"EHA 2022"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1302px;margin-left: calc(-5% \/ 2 );margin-right: calc(-5% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:2.375%;--awb-margin-bottom-large:0px;--awb-spacing-left-large:2.375%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:2.375%;--awb-spacing-left-medium:2.375%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:2.375%;--awb-spacing-left-small:2.375%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1 awb-text-cols fusion-text-columns-2\" style=\"--awb-text-transform:none;--awb-columns:2;--awb-column-spacing:2em;--awb-column-min-width:100px;\"><h2>SOMMAIRE<\/h2>\n<h3><\/h3>\n<p><span style=\"color: #cc99ff;\"><b>LEUC\u00c9MIES MY\u00c9LO\u00cfDES CHRONIQUES<\/b><\/span><\/p>\n<p><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/17\/quels-besoins-non-couverts-restent-ils-dans-la-lmc\/\">QUELS BESOINS NON COUVERTS RESTENT-ILS DANS LA LMC ?<\/a><br \/>\n<strong>\u00c9milie CAYSSIALS<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/17\/objectif-tfr-1ere-etape-remportee-par-le-nilotinib-versus-imatinib-avec-switch-precoce-vers-nilotinib\/\">Objectif TFR : 1<sup>\u00e8re<\/sup> \u00e9tape remport\u00e9e par le nilotinib <i>versus <\/i>imatinib avec<i> switch<\/i> pr\u00e9coce vers nilotinib<\/a><br \/>\n<strong>\u00c9milie CAYSSIALS, St\u00e9phane MORISSET<\/strong><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/17\/lmc-en-phase-acceleree-itks-versus-imatinib-en-1ere-ligne-quel-impact\/\">LMC en phase acc\u00e9l\u00e9r\u00e9e : ITKs <i>versus <\/i>imatinib en 1<sup>\u00e8re<\/sup> ligne : quel impact ?<\/a><br \/>\n<strong>\u00c9milie CAYSSIALS, St\u00e9phane MORISSET<\/strong><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/17\/quel-est-le-meilleur-schema-pour-administrer-le-ponatinib-pace-ou-optic\/\">Quel est le meilleur sch\u00e9ma pour administrer le ponatinib : PACE ou OPTIC ?<\/a><br \/>\n<strong>\u00c9milie CAYSSIALS, St\u00e9phane MORISSET<\/strong><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/17\/essai-transforme-pour-lasciminib-en-3eme-ligne\/\">Essai transform\u00e9 pour l\u2019asciminib en 3<sup>\u00e8me<\/sup> ligne !<\/a><br \/>\n<strong>\u00c9milie CAYSSIALS, St\u00e9phane MORISSET\u00a0<\/strong><\/li>\n<\/ul>\n<p><span style=\"color: #cc99ff;\"><b>LEUC\u00c9MIE AIGU\u00cb LYMPHOBLASTIQUE\u00a0<\/b><\/span><\/p>\n<p><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/17\/temps-forts-sur-la-leucemie-aigue-lymphoblastique-lal\/\">TEMPS FORTS SUR LA LEUC\u00c9MIE AIGU\u00cb LYMPHOBLASTIQUE (LAL)<\/a><br \/>\n<strong>Marie BALSAT<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/le-chemo-free-dans-le-traitement-des-lal-ph-de-ladulte-lhistoire-se-poursuit\/\">Le <i>chemo free<\/i> dans le traitement des LAL Ph+ de l\u2019adulte : l\u2019histoire se poursuit<\/a><br \/>\n<strong>Marie BALSAT, St\u00e9phane MORISSET\u00a0<\/strong><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/place-grandissante-de-la-pegasparaginase-dans-le-traitement-des-lal-ph-de-ladulte\/\">Place grandissante de la PEGASPARAGINASE dans le traitement des\u00a0LAL Ph- de l\u2019adulte<\/a><br \/>\n<strong>Marie BALSAT, St\u00e9phane MORISSET<\/strong><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/eliana-5-ans-apres\/\">Eliana, 5 ans apr\u00e8s<\/a><br \/>\n<strong>Marie BALSAT, St\u00e9phane MORISSET\u00a0<\/strong><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/lapport-de-la-biologie-moleculaire-dans-lidentification-de-nouveaux-facteurs-pronostiques-et-de-nouvelles-cibles-therapeutiques-dans-la-lal-t\/\">L\u2019apport de la biologie mol\u00e9culaire dans l\u2019identification de nouveaux facteurs pronostiques, et de nouvelles cibles th\u00e9rapeutiques dans la LAL-T<\/a><br \/>\n<strong>Marie BALSAT, St\u00e9phane MORISSET\u00a0<\/strong><\/li>\n<\/ul>\n<p><span style=\"color: #cc99ff;\"><b>LYMPHOMES\u00a0<\/b><\/span><\/p>\n<p><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/actualites-sur-les-lymphomes-a-leha-2022\/\">ACTUALIT\u00c9S SUR LES LYMPHOMES \u00c0 L\u2019EHA 2022<\/a><br \/>\n<strong>Beno\u00eet TESSOULIN\u00a0<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/natalite-et-beacopp-des-donnees-rassurantes\/\">Natalit\u00e9 et BEACOPP, des donn\u00e9es rassurantes<\/a><br \/>\n<strong>Beno\u00eet TESSOULIN, St\u00e9phane MORISSET\u00a0<\/strong><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/le-burkitt-au-codox-toute-une-epoch\/\">Le Burkitt au CODOX, toute une EPOCH<\/a><br \/>\n<strong>Beno\u00eet TESSOULIN, St\u00e9phane MORISSET<\/strong><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/du-dosage-a-la-fragmentomique-du-ctdna-dans-la-maladie-de-hodgkin-un-couteau-suisse-moleculaire\/\">Du dosage \u00e0 la fragmentomique du ctDNA dans la maladie de Hodgkin,\u00a0un couteau Suisse mol\u00e9culaire<\/a><br \/>\n<strong>Beno\u00eet TESSOULIN, St\u00e9phane MORISSET<\/strong><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/bright-study-un-manteau-brillant-qui-va-changer-les-pratiques\/\"><i>\u201cBright\u201d study<\/i> : un manteau brillant qui va changer les pratiques ?<\/a><br \/>\n<strong>Beno\u00eet TESSOULIN, St\u00e9phane MORISSET\u00a0<\/strong><\/li>\n<\/ul>\n<p><span style=\"color: #cc99ff;\"><b>Focus statistiques g\u00e9n\u00e9raux<\/b><\/span><\/p>\n<ul>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/quid-des-analyses-dites-ajustees\/\">Quid des analyses dites \u00ab\u00a0ajust\u00e9es\u00a0\u00bb<\/a><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/confection-dun-score-pronostic\/\">Confection d\u2019un score pronostic<\/a><\/li>\n<li><a href=\"https:\/\/convergences.online\/hemato\/2022\/10\/19\/lumap-uniform-manifold-approximation-and-projection-un-nouvel-outil-pour-les-data-scientists\/\">L\u2019UMAP un nouvel outil pour les <i>data scientists<\/i>\u00a0<\/a><\/li>\n<\/ul>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:60px;margin-bottom:60px;width:100%;\"><\/div><div class=\"fusion-blog-shortcode fusion-blog-shortcode-1 fusion-blog-archive fusion-blog-layout-large fusion-blog-pagination\"><div class=\"fusion-posts-container fusion-posts-container-pagination fusion-blog-rollover\" data-pages=\"2\"><article id=\"blog-1-post-16367\" class=\"fusion-post-large post-16367 post type-post status-publish format-standard hentry category-focus-statistiques-generaux tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/lumap-uniform-manifold-approximation-and-projection-un-nouvel-outil-pour-les-data-scientists\/\">L\u2019UMAP (Uniform Manifold Approximation and Projection), un nouvel outil pour les data scientists<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Le contexte Avec l\u2019incessante progression des performances informatiques et l\u2019explosion du big data, ce qu\u2019on appelle le machine learning, deep learning et autres algorithmes d\u2019intelligence artificielle se d\u00e9mocratisent de [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2022-10-19T10:22:55+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/focus-statistiques-generaux\/\" rel=\"category tag\">Focus statistiques g\u00e9n\u00e9raux<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/lumap-uniform-manifold-approximation-and-projection-un-nouvel-outil-pour-les-data-scientists\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/lumap-uniform-manifold-approximation-and-projection-un-nouvel-outil-pour-les-data-scientists\/\" aria-label=\"More on L\u2019UMAP (Uniform Manifold Approximation and Projection), un nouvel outil pour les data scientists\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-16365\" class=\"fusion-post-large post-16365 post type-post status-publish format-standard hentry category-focus-statistiques-generaux tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/confection-dun-score-pronostic\/\">Confection d\u2019un score pronostic<\/a><\/h2><div class=\"fusion-post-content-container\"><p>\u00a0 Le contexte Des scores pronostic, pr\u00e9dictifs, ou dits de risque, on en calcule dans de nombreuses cohortes de patients. On pense au score Sokal ou ELTS pour la [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2022-10-19T10:22:13+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/focus-statistiques-generaux\/\" rel=\"category tag\">Focus statistiques g\u00e9n\u00e9raux<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/confection-dun-score-pronostic\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/confection-dun-score-pronostic\/\" aria-label=\"More on Confection d\u2019un score pronostic\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-16363\" class=\"fusion-post-large post-16363 post type-post status-publish format-standard hentry category-focus-statistiques-generaux tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/quid-des-analyses-dites-ajustees\/\">Quid des analyses dites &#8220;ajust\u00e9es&#8221;<\/a><\/h2><div class=\"fusion-post-content-container\"><p>\u00a0 Le contexte Dans le cadre d\u2019analyses r\u00e9trospectives ou prospectives, il est souvent question de comparer l\u2019effet de deux ou plusieurs traitements ou un potentiel facteur de risque (\u00e2ge, [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2022-10-19T10:21:25+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/focus-statistiques-generaux\/\" rel=\"category tag\">Focus statistiques g\u00e9n\u00e9raux<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/quid-des-analyses-dites-ajustees\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/quid-des-analyses-dites-ajustees\/\" aria-label=\"More on Quid des analyses dites &#8220;ajust\u00e9es&#8221;\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-16361\" class=\"fusion-post-large post-16361 post type-post status-publish format-standard hentry category-decryptage-congres category-les-lymphomes tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/bright-study-un-manteau-brillant-qui-va-changer-les-pratiques\/\">\u201cBright\u201d study : un manteau brillant qui va changer les pratiques ?<\/a><\/h2><div class=\"fusion-post-content-container\"><p>R\u00e9sultats de l\u2019essai de phase 3 \u00ab SHINE \u00bb, association de l\u2019ibrutinib au rituximab et \u00e0 la bendamustine avec une maintenance par rituximab pour le traitement du lymphome \u00e0 [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2022-10-19T10:20:04+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/decryptage-congres\/\" rel=\"category tag\">D\u00e9cryptage congr\u00e8s<\/a>, <a href=\"https:\/\/www.hematostat.net\/en\/category\/les-lymphomes\/\" rel=\"category tag\">LES LYMPHOMES<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/bright-study-un-manteau-brillant-qui-va-changer-les-pratiques\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/bright-study-un-manteau-brillant-qui-va-changer-les-pratiques\/\" aria-label=\"More on \u201cBright\u201d study : un manteau brillant qui va changer les pratiques ?\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-16359\" class=\"fusion-post-large post-16359 post type-post status-publish format-standard hentry category-decryptage-congres category-les-lymphomes tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/du-dosage-a-la-fragmentomique-du-ctdna-dans-la-maladie-de-hodgkin-un-couteau-suisse-moleculaire\/\">Du dosage \u00e0 la fragmentomique du ctDNA dans la maladie de Hodgkin, un couteau Suisse mol\u00e9culaire<\/a><\/h2><div class=\"fusion-post-content-container\"><p>L\u2019ADN circulant tumoral, un bio-marqueur pronostic au diagnostic et qui am\u00e9liore la fiabilit\u00e9 des donn\u00e9es de TEP interm\u00e9diaire dans la maladie de Hodgkin. Circulating tumor DNA is a prognostic [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2022-10-19T10:19:18+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/decryptage-congres\/\" rel=\"category tag\">D\u00e9cryptage congr\u00e8s<\/a>, <a href=\"https:\/\/www.hematostat.net\/en\/category\/les-lymphomes\/\" rel=\"category tag\">LES LYMPHOMES<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/du-dosage-a-la-fragmentomique-du-ctdna-dans-la-maladie-de-hodgkin-un-couteau-suisse-moleculaire\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/du-dosage-a-la-fragmentomique-du-ctdna-dans-la-maladie-de-hodgkin-un-couteau-suisse-moleculaire\/\" aria-label=\"More on Du dosage \u00e0 la fragmentomique du ctDNA dans la maladie de Hodgkin, un couteau Suisse mol\u00e9culaire\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-16357\" class=\"fusion-post-large post-16357 post type-post status-publish format-standard hentry category-decryptage-congres category-les-lymphomes tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/le-burkitt-au-codox-toute-une-epoch\/\">Le Burkitt au CODOX, toute une EPOCH<\/a><\/h2><div class=\"fusion-post-content-container\"><p>R\u00e9sultats de l\u2019essai prospectif randomis\u00e9 des lymphomes de Burkitt de haut risque \u00e9valuant les traitements R-CODOX-M\/R-IVAC versus EPOCH-R-Modul\u00e9. R-CODOX-M\/R-IVAC versus dose-adjusted(da)- EPOCH-R-in patients with newly diagnosed high-risk burkitt lymphoma; [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2022-10-19T10:18:37+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/decryptage-congres\/\" rel=\"category tag\">D\u00e9cryptage congr\u00e8s<\/a>, <a href=\"https:\/\/www.hematostat.net\/en\/category\/les-lymphomes\/\" rel=\"category tag\">LES LYMPHOMES<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/le-burkitt-au-codox-toute-une-epoch\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/le-burkitt-au-codox-toute-une-epoch\/\" aria-label=\"More on Le Burkitt au CODOX, toute une EPOCH\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-16354\" class=\"fusion-post-large post-16354 post type-post status-publish format-standard hentry category-decryptage-congres category-les-lymphomes tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/natalite-et-beacopp-des-donnees-rassurantes\/\">Natalit\u00e9 et BEACOPP, des donn\u00e9es rassurantes<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Taux de natalit\u00e9 des patients porteurs d\u2019une maladie de Hogkin et trait\u00e9s par ABVD\u00a0et\/ou BEACOPP en Su\u00e8de, en Norv\u00e8ge ou au Danemark. Childbearing among classical hodgkin lymphoma survivors treated [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2022-10-19T10:17:11+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/decryptage-congres\/\" rel=\"category tag\">D\u00e9cryptage congr\u00e8s<\/a>, <a href=\"https:\/\/www.hematostat.net\/en\/category\/les-lymphomes\/\" rel=\"category tag\">LES LYMPHOMES<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/natalite-et-beacopp-des-donnees-rassurantes\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/natalite-et-beacopp-des-donnees-rassurantes\/\" aria-label=\"More on Natalit\u00e9 et BEACOPP, des donn\u00e9es rassurantes\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-16352\" class=\"fusion-post-large post-16352 post type-post status-publish format-standard hentry category-decryptage-congres category-les-lymphomes tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/actualites-sur-les-lymphomes-a-leha-2022\/\">ACTUALIT\u00c9S SUR LES LYMPHOMES \u00c0 L&#8217;EHA 2022<\/a><\/h2><div class=\"fusion-post-content-container\"><p> Pour cette \u00e9dition 2022 de l\u2019EHA, l\u2019immunoth\u00e9rapie a encore caracol\u00e9 en t\u00eate dans les h\u00e9mopathies lympho\u00efdes, avec une timide \u00e9mergence en dehors du spectre B. Lymphomes B agressifs [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2023-06-21T16:32:51+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/decryptage-congres\/\" rel=\"category tag\">D\u00e9cryptage congr\u00e8s<\/a>, <a href=\"https:\/\/www.hematostat.net\/en\/category\/les-lymphomes\/\" rel=\"category tag\">LES LYMPHOMES<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/actualites-sur-les-lymphomes-a-leha-2022\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/actualites-sur-les-lymphomes-a-leha-2022\/\" aria-label=\"More on ACTUALIT\u00c9S SUR LES LYMPHOMES \u00c0 L&#8217;EHA 2022\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-16350\" class=\"fusion-post-large post-16350 post type-post status-publish format-standard hentry category-decryptage-congres category-focus-statistiques-generaux category-leucemies-aigues tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/lapport-de-la-biologie-moleculaire-dans-lidentification-de-nouveaux-facteurs-pronostiques-et-de-nouvelles-cibles-therapeutiques-dans-la-lal-t\/\">L\u2019apport de la biologie mol\u00e9culaire  dans l\u2019identification de nouveaux facteurs pronostiques, et de nouvelles cibles th\u00e9rapeutiques dans la LAL-T<\/a><\/h2><div class=\"fusion-post-content-container\"><p>La caract\u00e9risation compl\u00e8te du g\u00e9nome r\u00e9v\u00e8le de nouveaux sous-types et des m\u00e9canismes de d\u00e9r\u00e9gulation des oncog\u00e8nes chez les enfants ayant une LAL-T. Comprehensive genome characterization reveals new subtypes and [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2022-10-19T10:15:27+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/decryptage-congres\/\" rel=\"category tag\">D\u00e9cryptage congr\u00e8s<\/a>, <a href=\"https:\/\/www.hematostat.net\/en\/category\/focus-statistiques-generaux\/\" rel=\"category tag\">Focus statistiques g\u00e9n\u00e9raux<\/a>, <a href=\"https:\/\/www.hematostat.net\/en\/category\/leucemies-aigues\/\" rel=\"category tag\">LEUC\u00c9MIES AIGU\u00cbS<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/lapport-de-la-biologie-moleculaire-dans-lidentification-de-nouveaux-facteurs-pronostiques-et-de-nouvelles-cibles-therapeutiques-dans-la-lal-t\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/lapport-de-la-biologie-moleculaire-dans-lidentification-de-nouveaux-facteurs-pronostiques-et-de-nouvelles-cibles-therapeutiques-dans-la-lal-t\/\" aria-label=\"More on L\u2019apport de la biologie mol\u00e9culaire  dans l\u2019identification de nouveaux facteurs pronostiques, et de nouvelles cibles th\u00e9rapeutiques dans la LAL-T\">Read More<\/a><\/div><\/div><\/article>\n<article id=\"blog-1-post-16348\" class=\"fusion-post-large post-16348 post type-post status-publish format-standard hentry category-decryptage-congres category-leucemies-aigues tag-eha-2022 author-marion\">\n\t<style type=\"text\/css\">\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\t<\/style>\n\n\n<div class=\"fusion-post-content post-content\"><h2 class=\"blog-shortcode-post-title entry-title\"><a href=\"https:\/\/www.hematostat.net\/en\/eliana-5-ans-apres\/\">Eliana, 5 ans apr\u00e8s<\/a><\/h2><div class=\"fusion-post-content-container\"><p>Tisagenlecleucel chez les patients p\u00e9diatriques et jeunes adultes ayant une LAL B en\u00a0rechute\/r\u00e9fractaire : r\u00e9sultats finaux de l\u2019\u00e9tude Eliana. Tisagenlecleucel in pediatric and young adult patients (pts) with relapsed\/refractory [...]<\/p><\/div><\/div><div class=\"fusion-clearfix\"><\/div><div class=\"fusion-meta-info\"><div class=\"fusion-alignleft\">By <span class=\"vcard\"><span class=\"fn\"><a href=\"https:\/\/www.hematostat.net\/en\/author\/marion\/\" title=\"Posts by HematoStat.net (M)\" rel=\"author\" itemprop=\"author\" itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/Person\">HematoStat.net (M)<\/a><\/span><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"updated\" style=\"display:none;\">2022-10-19T10:14:38+02:00<\/span><span>19 October 2022<\/span><span class=\"fusion-inline-sep\">|<\/span>Categories: <a href=\"https:\/\/www.hematostat.net\/en\/category\/decryptage-congres\/\" rel=\"category tag\">D\u00e9cryptage congr\u00e8s<\/a>, <a href=\"https:\/\/www.hematostat.net\/en\/category\/leucemies-aigues\/\" rel=\"category tag\">LEUC\u00c9MIES AIGU\u00cbS<\/a><span class=\"fusion-inline-sep\">|<\/span><span class=\"meta-tags\">Tags: <a href=\"https:\/\/www.hematostat.net\/en\/tag\/eha-2022\/\" rel=\"tag\">EHA 2022<\/a><\/span><span class=\"fusion-inline-sep\">|<\/span><span class=\"fusion-comments\"><a href=\"https:\/\/www.hematostat.net\/en\/eliana-5-ans-apres\/#respond\">0 Comments<\/a><\/span><\/div><div class=\"fusion-alignright\"><a class=\"fusion-read-more\" href=\"https:\/\/www.hematostat.net\/en\/eliana-5-ans-apres\/\" aria-label=\"More on Eliana, 5 ans apr\u00e8s\">Read More<\/a><\/div><\/div><\/article>\n<\/div><div class=\"pagination clearfix\"><span class=\"current\">1<\/span><a href=\"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/pages\/16369\/page\/2\/\" class=\"inactive\">2<\/a><a class=\"pagination-next\" rel=\"next\" href=\"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/pages\/16369\/page\/2\/\"><span class=\"page-text\">Next<\/span><span class=\"page-next\"><\/span><\/a><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-16369","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/pages\/16369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=16369"}],"version-history":[{"count":1,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/pages\/16369\/revisions"}],"predecessor-version":[{"id":17330,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/pages\/16369\/revisions\/17330"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=16369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}